Answers are grounded in this paper and cite their sources.
Chronic wounds pose a significant global health burden due to their recalcitrance, high recurrence, and infection risks. Traditional treatments often lack consistent efficacy, multifunctionality, and dynamic adaptability to wound healing stages, prolonging patient distress and worsening outcomes. Here, we introduce an innovative intelligent Wearable Ultrasound System (iWUS) that seamlessly integrates a highly miniaturized ultrasound driving circuit, a drug-loaded ultrasound patch for precisely controlled release of the antibacterial agent polyhexamethylene biguanide (PHMB), and a terminal for intuitive remote control, enabling noninvasive, on-demand ultrasound stimulation to simultaneously promote tissue regeneration and combat infection. The iWUS combines biocompatibility, flexibility, and conformability for intelligent chronic wound management. It introduces an on-demand dynamic therapy adapted to the wound microenvironment. In vitro assays showed sustained antibacterial action and enhanced cell migration. In vivo validation in a rat full-thickness wound model demonstrated programmable bacterial inhibition, inflammation modulation, and improved collagen remodeling, significantly accelerating wound closure and promoting structural and functional skin regeneration. RNA sequencing analysis revealed that iWUS treatment upregulated pro-healing genes (e.g., Bmp2, Egfr, Vegfd) while downregulating inflammatory pathways (e.g., NF-κB, Tnf), elucidating its molecular mechanism in promoting tissue repair and resolving inflammation. The work paves the way for next-generation wearable medical devices.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: